Mostrar el registro sencillo del ítem
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19
dc.contributor.author | Alunno, Alessia | |
dc.contributor.author | Najm, Aurelie | |
dc.contributor.author | Machado, Pedro M. | |
dc.contributor.author | Rodríguez Carrio, Javier | |
dc.date.accessioned | 2022-06-29T08:16:10Z | |
dc.date.available | 2022-06-29T08:16:10Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Annals of the Rheumatic Diseases (2021); doi:10.1136/annrheumdis-2021-221366 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issn | 1468-2060 | |
dc.identifier.uri | http://hdl.handle.net/10651/63565 | |
dc.description.sponsorship | European Alliance of Associations in Rheumatology (EULAR) [CLI122]; National Institute for Health Research (NIHR) University College London Hospitals (UCLH) Biomedical Research Centre (BRC); NIHR Newcastle Biomedical Research Centre in Ageing and Long-Term Conditions; Research Into Inflammatory Arthritis Centre vs Arthritis (...) | |
dc.description.statementofresponsibility | Alunno A, Najm A, Machado PM, Bertheussen H, Burmester GR, Carubbi F, De Marco G, Giacomelli R, Hermine O, Isaacs JD, Koné-Paut I, Magro-Checa C, McInnes IB, Meroni PL, Quartuccio L, Ramanan AV, Ramos-Casals M, Rodríguez Carrio J, Schulze-Koops H, Stamm TA, Tas SW, Terrier B, McGonagle DG, Mariette X. | |
dc.language.iso | eng | |
dc.relation.ispartof | Annals of the rheumatic diseases | |
dc.rights | © 2022 Los autores | |
dc.source | WOS:000722667300001 | |
dc.title | 2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 | |
dc.type | journal article | |
dc.identifier.doi | 10.1136/annrheumdis-2021-221366 | |
dc.relation.publisherversion | http://dx.doi.org/10.1136/annrheumdis-2021-221366 |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Artículos [35481]